Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Recruiting now NCT05887102
Run by CHU de Quebec-Universite Laval · for 18 and older · All sexes
What this study is about
The goal of this randomized controlled pilot study is to assess the feasibility, acceptability, and preliminary effects of the PACHA program designed for women having an adjuvant endocrine therapy (AET) after hormone-sensitive breast cancer. PACHA (programme en Pharmacie pour l'ACcompagnement des femmes ayant de l'Hormonothérapie Adjuvante) is a community pharmacy-based program aimed at optimizing the experience of AET and its use. The main questions it aims to answer are : * Does the program have an effect on factors expected to influence AET adherence? * Is the program acceptable? * Is the implementation of the program feasible? * What is the feasibility of procedures for carrying out a full-scale study? Participating community pharmacies will be randomized. Pharmacists working in pharmacies assigned to the PACHA group (33 pharmacies) will receive web-based training and manuals to use during their consultations with women having an AET. Recruited women attending these pharmacies will also have access to information and resources about AET (videos, evidence-based booklet). Pharmacists practicing in pharmacies assigned to the control group (33 pharmacies) will provide usual care.
Who can join (things the study team will check)
✅ You may be able to join if…
- In the province of Quebec, Canada
- At least one pharmacist agrees to take charge of the project in their pharmacy
- At least one women has initiated adjuvant endocrine therapy (AET) in the last 6 months in the pharmacy For pharmacists :
- Practicing in a pharmacy in the province of Quebec
- Provide consent For women :
- 18 years old or older
- Were diagnosed with a first non-metastatic, hormone-sensitive breast cancer
- Received and AET prescription for the first time in the last 6 months
- Are fluent in French
- Have internet access
- Provide consent
🚫 You may not be able to join if…
- Live in a residential facility where AET is not self-managed
Where this trial is running
- Centre de recherche du CHU de Québec, Québec, Quebec, Canada
Who to contact
Sophie Lauzier, Ph.D. · 418-682-7547 · sophie.lauzier@crchudequebec.ulaval.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT05887102.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.